Previous close | 96.00 |
Open | 96.28 |
Bid | 99.73 x 900 |
Ask | 100.02 x 900 |
Day's range | 95.39 - 102.95 |
52-week range | 49.19 - 103.66 |
Volume | |
Avg. volume | 509,409 |
Market cap | 4.964B |
Beta (5Y monthly) | 1.10 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Glaukos (GKOS) delivered earnings and revenue surprises of -20.69% and 8.83%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Comprehensive Analysis of Glaukos Corp's Latest Financial Performance
Medical Device companies' quarterly results are likely to reflect strength in customer demand. Let's see how COR, GKOS, SRDX and ARAY are placed ahead of their earnings releases.